Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
13.01
-0.02 (-0.15%)
Oct 5, 2026, 9:30 AM EDT - Market open
ARCT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29.37 | 82.03 | 152.31 | 166.8 | 206 | 12.36 | |
Revenue Growth | -75.95% | -46.14% | -8.69% | -19.03% | 1566.79% | 29.56% |
Cost of Revenue | 86.78 | 112.21 | 195.16 | 192.13 | 147.75 | 173.76 |
Gross Profit | -57.42 | -30.18 | -42.85 | -25.33 | 58.25 | -161.4 |
Selling, General & Admin | 44.88 | 46.08 | 52.82 | 52.87 | 46.07 | 41.45 |
Operating Expenses | 44.88 | 46.08 | 52.82 | 52.87 | 46.07 | 41.45 |
Operating Income | -102.29 | -76.26 | -95.67 | -78.21 | 12.18 | -202.85 |
Interest Expense | -0.01 | -0.01 | - | - | - | - |
Interest & Investment Income | 8.52 | 10.1 | 15.2 | 16.59 | - | - |
Earnings From Equity Investments | - | - | - | - | -0.52 | 0.52 |
Currency Exchange Gain (Loss) | 0.38 | 0.38 | -0.47 | -0.23 | -0.6 | 0.58 |
Other Non Operating Income (Expenses) | 0.13 | - | - | - | -0.42 | -1.92 |
EBT Excluding Unusual Items | -93.28 | -65.78 | -80.95 | -61.84 | 10.64 | -203.67 |
Other Unusual Items | - | - | - | 33.95 | - | - |
Pretax Income | -93.28 | -65.78 | -80.95 | -27.89 | 10.64 | -203.67 |
Income Tax Expense | -0 | - | -0 | 1.84 | 1.3 | - |
Net Income | -93.28 | -65.78 | -80.94 | -29.73 | 9.35 | -203.67 |
Net Income to Common | -93.28 | -65.78 | -80.94 | -29.73 | 9.35 | -203.67 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 28 | 27 | 27 | 27 | 26 | 26 |
Shares Outstanding (Diluted) | 28 | 27 | 27 | 27 | 27 | 26 |
Shares Change | 3.47% | 1.43% | 1.40% | -1.72% | 2.95% | 29.61% |
EPS (Basic) | -3.33 | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 |
EPS (Diluted) | -3.33 | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -72.82 | -74.5 | -60.4 | -21 | 24.27 | -138.45 |
Free Cash Flow Per Share | -2.60 | -2.72 | -2.24 | -0.79 | 0.90 | -5.26 |
Gross Margin | -195.50% | -36.79% | -28.13% | -15.19% | 28.28% | - |
Operating Margin | -348.32% | -92.97% | -62.81% | -46.89% | 5.91% | -1641.33% |
Profit Margin | -317.61% | -80.19% | -53.14% | -17.82% | 4.54% | -1647.98% |
Free Cash Flow Margin | -247.96% | -90.82% | -39.65% | -12.59% | 11.78% | -1120.23% |
EBITDA | -99.55 | -73.24 | -92.13 | -75.25 | 13.7 | -201.66 |
EBITDA Margin | - | -89.28% | -60.48% | -45.11% | 6.65% | - |
D&A For EBITDA | 2.75 | 3.03 | 3.54 | 2.96 | 1.53 | 1.19 |
EBIT | -102.29 | -76.26 | -95.67 | -78.21 | 12.18 | -202.85 |
EBIT Margin | - | -92.97% | -62.81% | -46.89% | 5.91% | - |
Effective Tax Rate | - | - | - | - | 12.17% | - |
Revenue as Reported | 29.37 | 82.03 | 152.31 | 166.8 | 206 | 12.36 |